Stockreport

Keros Therapeutics considers sale amid investor pressure [Yahoo! Finance]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF The move comes after certain investors – including one individual holding 11.2% of Keros's outstanding common stock as of 6 April 2025 – expressed a desire to shape the [Read more]